US Patent Issued to Lhotse Bio on Sept. 30 for "Compounds and compositions for treating conditions associated with LPA receptor activity" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,375, issued on Sept. 30, was assigned to Lhotse Bio Inc. (South San Francisco, Calif.).

"Compounds and compositions for treating conditions associated with LPA receptor activity" was invented by Wei Huang (Shanghai), Hui Lei (Shanghai), Zhongmiao Xu (Shanghai), Haizhen Zhang (Shanghai) and Qiong Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides LPA antagonists, as well as pharmaceutical compositions comprising the compounds disclosed herein. Also provided are methods for treating LPA-associated diseases, disorders, and conditions."

The patent was filed on Dec. 8, 2023, under Application No. 18/534,520....